Comprehensive analysis of PD ‐L1 in non‐small cell lung cancer with emphasis on survival benefit, impact of driver mutation and histological types, and archival tissue

ConclusionsThere were a trend or significant differences in PD-L1 expression between different histological types in NSCLC, different EGFR and ALK status, and different tumor tissue storage time. A higher survival benefit was observed in no PD-L1 expression than with PD-L1 expression in adenocarcinoma,EGFR andALK mutation patients. We recommend that PD-L1 assay should be performed as early as possible if tissue is available.

Source: Thoracic Cancer - November 30, 2021 Category: Cancer & Oncology Authors: Chin ‐Chou Wang, Kuo‐Tung Huang, Huang‐Chih Chang, Chia‐Cheng Tseng, Chien‐Hao Lai, Jui Lan, Ting‐Ting Liu, Chao‐Cheng Huang, Meng‐Chih Lin Tags: ORIGINAL ARTICLE Source Type: research